About Longeveron
Longeveron is a company based in Miami (United States) founded in 2014 by Joshua M Hare.. Longeveron has raised $1.05 million across 8 funding rounds from investors including NIH, HHS and TEDCO. The company has 26 employees as of December 31, 2024. Longeveron offers products and services including Lomecel-B. Longeveron operates in a competitive market with competitors including Edesa Biotech, T3D Therapeutics, Alzheon, Vivoryon and Alchemab, among others.
- Headquarter Miami, United States
- Employees 26 as on 31 Dec, 2024
- Founders Joshua M Hare
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Longeveron Inc.
-
Annual Revenue
$2.39 M237.38as on Dec 31, 2024
-
Net Profit
$-15.97 M25.41as on Dec 31, 2024
-
EBITDA
$-15.56 M20.93as on Dec 31, 2024
-
Total Equity Funding
$1.05 M (USD)
in 8 rounds
-
Latest Funding Round
$20.46 M (USD), Post-IPO
Dec 01, 2021
-
Investors
NIH
& 3 more
-
Employee Count
26
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Longeveron
Longeveron is a publicly listed company on the NASDAQ with ticker symbol LGVN in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Longeveron
Longeveron offers a comprehensive portfolio of products and services, including Lomecel-B. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Stem cell-based treatment for heart and neurodegenerative diseases
Unlock access to complete
Unlock access to complete
Funding Insights of Longeveron
Longeveron has successfully raised a total of $1.05M across 8 strategic funding rounds. The most recent funding activity was a Post-IPO round of $20.46 million completed in December 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 8
- Last Round Post-IPO — $20.5M
-
First Round
First Round
(22 May 2017)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2021 | Amount | Post-IPO - Longeveron | Valuation |
investors |
|
| Feb, 2020 | Amount | Seed - Longeveron | Valuation |
investors |
|
| Nov, 2018 | Amount | Grant - Longeveron | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Longeveron
Longeveron has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include NIH, HHS and TEDCO. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital fund and startup accelerator programs focused on seed and early stage companies
|
Founded Year | Domain | Location | |
|
Stem cell research startups in healthcare are funded and accelerated.
|
Founded Year | Domain | Location | |
|
Drug discovery services are provided to the biopharma sector.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Longeveron
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Longeveron
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Longeveron Comparisons
Competitors of Longeveron
Longeveron operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Edesa Biotech, T3D Therapeutics, Alzheon, Vivoryon and Alchemab, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Topical therapeutics for dermatological and gastrointestinal diseases are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for neurodegenerative diseases, including Alzheimer's, are developed.
|
|
| domain | founded_year | HQ Location |
Oral inhibitors of amyloid aggregation for Alzheimer's treatment are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutic agents for age-related diseases like Alzheimer's are developed.
|
|
| domain | founded_year | HQ Location |
Developer of antibody based therapeutics to treat cancers, neurodegenerative conditions and infectious diseases
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Longeveron
Frequently Asked Questions about Longeveron
When was Longeveron founded?
Longeveron was founded in 2014 and raised its 1st funding round 3 years after it was founded.
Where is Longeveron located?
Longeveron is headquartered in Miami, United States. It is registered at Miami, Florida, United States.
Is Longeveron a funded company?
Longeveron is a funded company, having raised a total of $1.05M across 8 funding rounds to date. The company's 1st funding round was a Grant of $6.7M, raised on May 22, 2017.
How many employees does Longeveron have?
As of Dec 31, 2024, the latest employee count at Longeveron is 26.
What is the annual revenue of Longeveron?
Annual revenue of Longeveron is $2.39M as on Dec 31, 2024.
What does Longeveron do?
Longeveron was founded in 2014 in Miami, United States, within the biotechnology sector focused on cellular therapies. Operations center on the development of treatments derived from culture-expanded medicinal signaling cells sourced from adult human bone marrow donors. The lead candidate, Lomecel-B, is targeted at conditions including aging frailty, Alzheimers disease, metabolic syndrome, acute respiratory distress syndrome, and hypoplastic left heart syndrome.
Who are the top competitors of Longeveron?
Longeveron's top competitors include Alzheon, Alchemab and Edesa Biotech.
What products or services does Longeveron offer?
Longeveron offers Lomecel-B.
Is Longeveron publicly traded?
Yes, Longeveron is publicly traded on NASDAQ under the ticker symbol LGVN.
Who are Longeveron's investors?
Longeveron has 4 investors. Key investors include NIH, HHS, TEDCO, and Maryland Stem Cell Research Fund.
What is Longeveron's ticker symbol?
The ticker symbol of Longeveron is LGVN on NASDAQ.